Prognosis value of Forrester's classification in advanced heart failure patients awaiting heart transplantation.

Advanced heart failure Cardiac oedema Cardiovascular diseases Forrester's classification Heart transplant

Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
10 2022
Historique:
revised: 04 05 2022
received: 07 02 2022
accepted: 03 06 2022
pubmed: 9 7 2022
medline: 6 12 2022
entrez: 8 7 2022
Statut: ppublish

Résumé

The value of Forrester's perfusion/congestion profiles assessed by invasive catheter evaluation in non-inotrope advanced heart failure patients listed for heart transplant (HT) is unclear. We aimed to assess the value of haemodynamic evaluation according to Forrester's profiles to predict events on the HT waitlist. All non-inotrope patients (n = 837, 79% ambulatory at listing) registered on the French national HT waiting list between 1 January 2013 and 31 December 2019 with right heart catheterization (RHC) were included. The primary outcome was a combined criteria of waitlist death, delisting for aggravation, urgent HT or left ventricular assist device implantation. Secondary outcome was waitlist death. The 'warm-dry', 'cold-dry', 'warm-wet', and 'cold-wet' profiles represented 27%, 18%, 27%, and 28% of patients, respectively. At 12 months, the respective rates of primary outcome were 15%, 17%, 25%, and 29% (P = 0.008). Taking the 'warm-dry' category as reference, a significant increase in the risk of primary outcome was observed only in the 'wet' categories, irrespectively of 'warm/cold' status: hazard ratios, 1.50; 1.06-2.13; P = 0.024 in 'warm-wet' and 1.77; 1. 25-2.49; P = 0.001 in 'cold-wet'. Haemodynamic assessment of advanced HF patients using perfusion/congestion profiles predicts the risk of the combine endpoint of waitlist death, delisting for aggravation, urgent heart transplantation, or left ventricular assist device implantation. 'Wet' patients had the worst prognosis, independently of perfusion status, thus placing special emphasis on the cardinal prominence of persistent congestion in advanced HF.

Identifiants

pubmed: 35801277
doi: 10.1002/ehf2.14037
pmc: PMC9715881
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3287-3297

Informations de copyright

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

J Clin Med. 2019 Oct 22;8(10):
pubmed: 31652650
ESC Heart Fail. 2022 Oct;9(5):3287-3297
pubmed: 35801277
Cardiovasc Drugs Ther. 2016 Dec;30(6):599-609
pubmed: 27819111
Lancet. 2016 Jan 30;387(10017):453-61
pubmed: 26560249
Eur J Heart Fail. 2016 Mar;18(3):328-36
pubmed: 26693947
Eur J Heart Fail. 2015 Nov;17(11):1172-81
pubmed: 26417699
Circulation. 2003 Jul 29;108(4):492-7
pubmed: 12885733
Am J Cardiol. 1990 Dec 1;66(19):1348-54
pubmed: 2244566
Eur J Heart Fail. 2021 May;23(5):703-712
pubmed: 33118672
Am J Transplant. 2020 May;20(5):1236-1243
pubmed: 32037718
J Am Coll Cardiol. 2003 May 21;41(10):1797-804
pubmed: 12767667
Circ Heart Fail. 2015 Sep;8(5):880-6
pubmed: 26179184
Eur J Heart Fail. 2016 Jul;18(7):736-43
pubmed: 27220672
N Engl J Med. 1976 Dec 9;295(24):1356-62
pubmed: 790191
Circulation. 1997 Jun 17;95(12):2660-7
pubmed: 9193435
Eur J Heart Fail. 2019 Nov;21(11):1338-1352
pubmed: 31127678
Int J Cardiol. 2013 Sep 10;167(6):2710-8
pubmed: 22795401
N Engl J Med. 1976 Dec 16;295(25):1404-13
pubmed: 790194
Eur Heart J. 2013 May;34(19):1404-13
pubmed: 23095984
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Card Fail. 2001 Jun;7(2):105-13
pubmed: 11420761
Am J Cardiol. 1994 Feb 15;73(5):379-83
pubmed: 8109553
J Card Fail. 2016 Mar;22(3):182-9
pubmed: 26703245
Lancet. 2021 Sep 11;398(10304):991-1001
pubmed: 34461042
Int J Cardiol. 2019 Apr 15;281:62-68
pubmed: 30718133
Eur J Heart Fail. 2019 Jun;21(6):732-743
pubmed: 30843353
Eur J Heart Fail. 2019 Feb;21(2):137-155
pubmed: 30600580
Eur J Heart Fail. 2014 Aug;16(8):898-906
pubmed: 24920349
Eur J Heart Fail. 2019 Dec;21(12):1605-1613
pubmed: 31667987
N Engl J Med. 2017 Nov 16;377(20):1964-1975
pubmed: 29141174
JACC Heart Fail. 2020 Mar;8(3):157-168
pubmed: 31838029
Eur J Heart Fail. 2018 Nov;20(11):1505-1535
pubmed: 29806100
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Eur Heart J. 2013 Mar;34(11):835-43
pubmed: 23293303
Circ Heart Fail. 2017 May;10(5):
pubmed: 28465311
J Card Fail. 2020 Feb;26(2):128-135
pubmed: 31442494
Transplantation. 2017 Sep;101(9):2175-2182
pubmed: 28272288

Auteurs

Guillaume Baudry (G)

Department of heart failure and transplantation, Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, 69500, Bron, France.
Centre d'Investigations Cliniques Plurithématique 1433, INSERM DCAC, CHRU de Nancy, F-CRIN INI-CRCT, Université de Lorraine, 54500, Vandoeuvre-lès-Nancy, Nancy, France.

Guillaume Coutance (G)

Department of Cardiac and Thoracic Surgery, Cardiology Institute, Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP). Sorbonne University Medical School, Paris, France.

Richard Dorent (R)

Department of Cardiac Surgery, CHU Bichat-Claude Bernard, AP-HP, Université Paris VII, 75877, Paris, France.

Fabrice Bauer (F)

Department of Cardiology and Cardiovascular Surgery, Hospital Charles Nicolle, Rouen, France.

Katrien Blanchart (K)

Department of Cardiology and Cardiac Surgery, University Hospital of Caen, University of Caen, Caen, France.

Aude Boignard (A)

Department of Cardiology and Cardiovascular Surgery, CHU Michallon, Grenoble, France.

Céline Chabanne (C)

Department of Thoracic and Cardiovascular Surgery, CHU Pontchaillou, Inserm U1099, 35000, Rennes, France.

Clément Delmas (C)

Department of Cardiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Nicolas D'Ostrevy (N)

Cardiology and Cardiac Surgery Department, CHU Clermont-Ferrand, Clermont-Ferrand, France.

Eric Epailly (E)

Department of Cardiology and Cardiovascular Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Vlad Gariboldi (V)

Department of Cardiac Surgery, La Timone Hospital, Marseille, France.

Philippe Gaudard (P)

Department of Cardiac Surgery, Anesthesiology and Critical Care Medicine, Arnaud de Villeneuve Hospital, CHRU Montpellier, Montpellier, France.

Céline Goéminne (C)

Department of Cardiac Surgery, CHU Lille, Institut Coeur Poumons, Lille, France.

Sandrine Grosjean (S)

Department of Cardiology and Cardiac Surgery, University Hospital of Dijon, Dijon, France.

Julien Guihaire (J)

Department of Cardiothoracic Surgery, Marie Lannelongue Hospital, University of Paris Sud, Inserm U999 [Pulmonary Hypertension: Pathophysiology and Novel Therapies (PAH)], 92350, Le Plessis Robinson, France.

Romain Guillemain (R)

Cardiology and Cardiac Surgery Department, European Georges Pompidou Hospital, Paris, France.

Mathieu Mattei (M)

Department of Cardiology and Cardiac Surgery, CHU de Nancy, Hopital de Brabois, Nancy, France.

Karine Nubret (K)

Department of Thoracic and Cardiovascular Surgery, Hôpital Cardiologique du Haut-Lévêque, Université Bordeaux II, Bordeaux, France.

Sabine Pattier (S)

Department of Cardiology and Heart Transplantation Unit, CHU de Nantes, Nantes, France.

Matteo Pozzi (M)

Department of heart failure and transplantation, Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, 69500, Bron, France.

Patrick Rossignol (P)

Centre d'Investigations Cliniques Plurithématique 1433, INSERM DCAC, CHRU de Nancy, F-CRIN INI-CRCT, Université de Lorraine, 54500, Vandoeuvre-lès-Nancy, Nancy, France.

Emmanuelle Vermes (E)

Cardiothoracic Surgery Department, Tours University Hospital, Tours, France.

Laurent Sebbag (L)

Department of heart failure and transplantation, Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, 69500, Bron, France.

Nicolas Girerd (N)

Centre d'Investigations Cliniques Plurithématique 1433, INSERM DCAC, CHRU de Nancy, F-CRIN INI-CRCT, Université de Lorraine, 54500, Vandoeuvre-lès-Nancy, Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH